The debate continues over long-term outcomes of percutaneous coronary intervention (PCI) vs. coronary artery bypass grafting (CABG) in patients with non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel disease.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
percutaneous revascularization
February 14, 2025
Dr. David Taggart delivered a presentation on “Maintaining CABG as a Gold Standard In 2024,” explaining the three reasons for persisting survival benefits of CABG over PCI.